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It was also clear at that time that internationalization had just begun.
Submissions from Japan had constituted only about 5% of the total in
1977, but more than doubled by 1982. Moreover, the quality of Japanese
papers was improving significantly, as reflected in increasing acceptance
rates. Now, ten years later, this trend can be seen to have presaged the
enormous involvement of Japanese scientists in investigative dermato-
logy, as reflected in the pages of JID.
In preparing this retrospective, I have pondered on my place in
the history of the Journal. The Editor of a major scientific journal has a
unique opportunity and an awesome responsibility which I defined in my
first Editorial ( J Invest Dermatol 69:193, 1977). The responsibility that I
perceived was to ‘‘enlist the partnership, critical input and contributions
of all segments of the community of investigators of the skin.’’ The
opportunity was to imprint my personal philosophy of excellence and
produce a journal which reflected the ‘‘broad mixture of biological
enquiries that is essential if research in dermatology is to be meaningfully
translated into help for the patient.’’
There were times during my years when these grand objectives seemed
impossibly hard and when the day-to-day tasks overwhelmed the broad
goals. On the whole, I trust that I steered the Journal on a straight course
during times of great change and faithfully discharged my responsibilities
as I saw them. The Journal I handed over to my successor was better than
the one I received, but only because the Science was better and more
mature. Some of my goals were achieved, in particular that of cementing
the international support of the Journal. Others were passed on to the next
Editor only partially fulfilled. Chief among these was the desire to make the
JID a journal reflecting the whole broad scientific base of dermatology.
But, in truth, this is a goal that cannot be fulfilled, but rather should be a
light on the path to the future; for the answer to each scientific question
brings new questions and new ways of answering them. I believe that,
during my years, the Journal encompassed the most relevant questions and
answers of the time. The challenge to its future is to continue successfully
on that path during the next 50 years. As one of its long line of foster
parents, I wish for it continued good fortune.
Prosperity and Growth
Howard P. Baden, M.D. (1982–1987)
Not long after assuming the editorship, I wondered whatever possessed
me to take the job. I was working night and day, weekends included, and
felt insecure about decisions because of severe limitations of space. Both
the SID and ESDR were concerned about the rising costs of running the
Journal, and I had all these terrific papers to publish, some of which I had
to reject for lack of room. The phone calls and letters I received during
the first years had me looking over my shoulder on dark streets.
The worst part of it was that the quality of science was increasing at
an ever-faster pace. Probably leading the pack was immunology, with the
T cell and Langerhans cells threatening to take over the office. I had to
learn the language: I’m OK, you’re OK. I was elated by the helpers and
depressed by the suppressors. In a more serious vain, I was seeing really
good stuff, and I began to lose my despair and enjoy the revolution of
which I was a participant. It was also easier when I learned if some
reviewers said good, it meant great, and the reverse held true for others. I
do feel that the authors were generally understanding but not happy, and
it became clear that something needed to be done.
The first priority was to try and find a less-expensive way of
publishing the Journal. Our old publishers, Williams and Wilkins, were
willing to make some concessions, but could not match the other
companies that we contacted. Unfortunately, the quest for a new
publisher who could perform the same quality job as Williams and
Wilkins was time-consuming and dragged out much longer than I had
hoped. Ultimately, we settled on Elsevier, a publisher we felt could
maintain the quality, but lower our costs. The decision was made, and
we were off and running. While we were at it, we did some revamping,
including changing colors. Pat Novak was instrumental in picking the
cover design and color. What is in-between the covers is the most
important factor, but presentation of material helps a great deal.
While on the subject of Pat, I should comment on how important her
contribution to the Journal really was. I would say that after her editing of
many papers, although the science was no different, the method of
presentation and organization of data led to a much-improved manu-
script. Readability is key, particularly with topics with which one might
not be so familiar, and she helped a great deal.
So now, with a new publisher under our belts, we went after more
pages. But by this time it was easy. Both societies recognized that
publishing good work was the most important consideration, and
somehow the money would be found. Page charges were started and,
although it was suggested by some it would be our downfall, it was
accepted with a minimum of complaint.
In order to ensure that the financial resources would be available to
allow the Journal to expand in proportion to its needs, the Board of the
Society undertook to raise an endowment for the Journal. Generation of
income from advertisements and charges to authors cannot be expected to
grow by a significant amount, and it is therefore essential that a new source
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of income be sought. This project is underway, and significant amounts of
money have been raised from our membership, industry and private
individuals. All of us can help by lending support to this effort, both by our
own giving and by identifying potential donors.
I was really pleased with what had occurred. The quality of the papers
kept increasing, the number of published reports was growing, manu-
scripts were being submitted from non-dermatology laboratories, and
more space was available.
There were some disappointments, however; the world is not a perfect
place. Early along I had tried to get editorials written which were related to
some paper published in that issue. This was not original with me, but had
not yet been done in any dermatology journal. One difficulty was that you
had to get someone to do this in a short period of time, since we had
drastically reduced the length of time from submission to publication. I
think the editorial is extremely valuable because it allows one to explore
other fields that seem too difficult to enter through an original report. The
editorials are like a guide which leads you through and points out the
major concepts. It is difficult to do properly, and I was not as effective as I
would have like to have been in getting people to write them. I think it has
advantages over review articles which often are so crammed with details
that they turn off the reader not familiar with the field.
An outgrowth of the editorials was Gina Kolata’s ‘‘What’s News.’’
This format was shorter than the editorial, but had the advantages of
using the talents and expertise of the science writer. Our initial intent was
to use this to attract the non-scientists as members of our society and
keep them informed of what was going on at the cutting edge. A separate
committee was formed to carry this out, since the growth of the Journal
precluded my participation.
One final important event which occurred was the recognition
by both the ESDR and SID that they had to talk more about their
needs and goals. I attended all the ESDR meetings and was welcomed
warmly by the membership. I participated in their various meetings
and encouraged them to be less-passive partners, because it seemed
that such a course threatened to lead to dissolution of the partnership
and creation of a new journal. I would like to think that my inter-
action with them helped the obviously improved relationship that
now exists between the two societies. We can’t be lulled by the
past, but must keep the dialogue alive and continue to seek new ways of
working together, so that both societies can share in the decisions that
must be made about the management, content and direction of the
Journal.
I know that 50 years from now what is being currently published will
probably not appear very sophisticated, but I am certain that we will be
considered on an equal level with other scientific journals of our time.
Molecular biology is rapidly being incorporated into many fields of
research and offers new tools to answer questions more accurately and
rapidly. There will be other new methodologies that will evolve as
science expands at an even more rapid rate in the twenty-first century.
These advances will also be a part of the research in dermatology, and
the pages of our Journal will reflect this new knowledge. What will not
change is the imaginative and creative approach to the problems which
arise in studying the biology of the skin. When I browse through issues of
the Journal, I am pleased and excited by the questions that are being
asked and the incredible intellectual effort that is being brought to
scientific thought.
I feel good about the future.
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